Abstract
PurposeTo assess the predictive value of combining CT and clinical findings for predicting 10-day mortality in critically ill patients in shock. Materials and methodsFrom January 1, 2018, to December 31, 2021, 289 consecutives critically ill patients in shock who underwent a contrast enhanced CT were included. Variables at the time of the CT were retrospectively extracted from medical charts. CT examinations were blindly analyzed by two independent radiologists. Multivariable analysis was performed, combining clinical and CT features. A simple survival score for 10-day mortality prediction was built and validated in a further independent external cohort of 70 patients. Results10-day mortality rate was 135/289 (47%) in the study sample. At multivariate analysis, catecholamine infusion (OR = 2.11; 95%CI [1.21–4.18], P = 0.011), lactates level > 5 mmol/l (OR = 3.54; 95%CI [1.94–6.54], P < 0.001); total bilirubin > 50 mg/l (OR = 1.79 CI 95% [1.03–3.13], P = 0.039); small bowel dilation (OR = 1.82; 95%CI [1.01–3.32], P = 0.047); diffuse kidney infarction (OR = 2.76; 95%CI [1.26–6.37], P = 0.013) and superior mesentery artery < 5 mm (OR = 1.96; 95%CI [1.10–3.49], P = 0.021) were associated with 10-days mortality. The AUC of the combined model was 0.79; 95%CI [0.74–0.85] in the study sample and 0.87; 95%CI [0.71–0.91] in the validation cohort. ConclusionThe combination of CT imaging features and clinical data should emerge as a novel approach to predict short-term mortality in critically ill patients in shock.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.